Skip to main content
. Author manuscript; available in PMC: 2022 Mar 29.
Published in final edited form as: Biomed Pharmacother. 2020 Nov 27;133:110936. doi: 10.1016/j.biopha.2020.110936

Fig. 7.

Fig. 7.

Blood clearance and the tumor-to-muscle ratio of 99mTc-NE-LAP. A) Blood circulation of99mTc-NE-LAP after intravenous administration in healthy BALC/c female mice. All data are the mean percentage (n = 7) of the injected dose of per gram of blood, ± the standard deviation of the mean. B) Tumor-to-muscle ratio at 1, 4, 8 and 24 h after intravenous administration of 99mTc-NE-LAP in 4T1 tumor-bearing mice (n = 7).